Karl K. Chan

Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

When Cholesterol Can Kill at 20: Recognizing and Managing Homozygous Familial Hypercholesterolemia in the Young.

When Cholesterol Can Kill at 20: Recognizing and Managing Homozygous Familial Hypercholesterolemia in the Young.

Journal: JACC. Case reports

Published: June 11, 2026

The Hong Kong Registry for Percutaneous Ventricular Assist Device.

The Hong Kong Registry for Percutaneous Ventricular Assist Device.

Journal: JACC. Asia

Published: November 03, 2025

Multimodality Imaging of a Woman With Hypertrophic Cardiomyopathy and Fabry Disease.

Multimodality Imaging of a Woman With Hypertrophic Cardiomyopathy and Fabry Disease.

Journal: Echocardiography (Mount Kisco, N.Y.)

Published: August 17, 2025

Multimodality Imaging of Aortic Valve Tendon Mimicking Aortic Dissection.

Multimodality Imaging of Aortic Valve Tendon Mimicking Aortic Dissection.

Journal: Journal of cardiovascular echography

Published: October 13, 2024

The Double Bioadaptors Culotte (ADAPT-CULOTTE) Technique: From Bench Testing to the First-in-Human Longitudinal Imaging Analysis.

The Double Bioadaptors Culotte (ADAPT-CULOTTE) Technique: From Bench Testing to the First-in-Human Longitudinal Imaging Analysis.

Journal: JACC. Cardiovascular interventions

Published: September 05, 2024

A Man with an Usual Cause of Mitral Insufficiency.

A Man with an Usual Cause of Mitral Insufficiency.

Journal: Journal of cardiovascular echography

Published: June 04, 2024

Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccine.

Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccine.

Journal: Vaccine

Published: May 17, 2024

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination.

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination.

Journal: Virology journal

Published: February 14, 2024

Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents.

Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents.

Journal: World journal of pediatrics : WJP

Published: June 26, 2023

Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents.

Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents.

Journal: Frontiers in immunology

Published: November 24, 2022

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial.

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial.

Journal: The Lancet. Microbe

Published: September 09, 2022

Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents.

Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents.

Journal: Nature communications

Published: August 15, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026